Replacement of the Valves of a Novacor LVAS Without Cardiopulmonary Bypass

We report the case of a 54-year old man with end-stage heart disease in whom the malfunctioning valves of a Novacor LVAS needed to be replaced after 490 days of circulatory support. This procedure could be performed without cardiopulmonary bypass.

Key words:

Mechanical circulatory assist - Infection - Valve

References

• 1 Argenziano M, Catanese K A, Moazami N. et al . The influence of infection on survival and successful transplantation in patients with left ventricular assist devices.  J Heart Lung Transplant. 1997;  16 822-831
• 2 Herrmann M, Weyand M, Greshake B. et al . Left ventricular assist device infection is associated with increased mortality but is not a contraindication to transplantation.  Circulation. 1997;  95 814-817
• 3 Kilger E, Strom C, Frey L. et al . Intermittent atrial level right-to-left shunt with temporary hypoxemia in a patient during support with a left ventricvlar assist device.   Acta Anaesthesiol Scand. 2000;  49 125-127
• 4 Parameshwar J, Wallwork J. Left Ventricular assist devices: current status and future applications.  Int J Cardiol. 1997;  62 ( (Suppl 1)) 523-527
• 5 Laks H, Scholl F G, Drinkwater D C. et al . The alternate recipient list for heart transplantation: does it work?.  J Heart Lung Transplant. 1997;  16 735-742
• 6 Jarvik R, Westaby S, Katsumata T, Pigott D, Evans R D. LVAD power delivery: a percutaneous approach to avoid infection.  Ann Thorac Surg. 1998;  65 470-473

Received for Publication: March 9, 2000